177 related articles for article (PubMed ID: 17529899)
41. Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.
Kees MG; Steinke T; Moritz S; Rupprecht K; Paulus EM; Kees F; Bucher M; Faerber L
J Clin Pharmacol; 2012 Aug; 52(8):1265-72. PubMed ID: 21903891
[TBL] [Abstract][Full Text] [Related]
42. Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?
Bolin P; Gohh R; Kandaswamy R; Shihab FS; Wiland A; Akhlaghi F; Melancon K
Transplant Rev (Orlando); 2011 Jul; 25(3):117-23. PubMed ID: 21530217
[TBL] [Abstract][Full Text] [Related]
43. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data.
Trkulja V; Lalić Z; Nađ-Škegro S; Lebo A; Granić P; Lovrić M; Pasini J; Božina N
Ther Drug Monit; 2014 Aug; 36(4):456-64. PubMed ID: 24518562
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.
Sommerer C; Müller-Krebs S; Schaier M; Glander P; Budde K; Schwenger V; Mikus G; Zeier M
Br J Clin Pharmacol; 2010 Apr; 69(4):346-57. PubMed ID: 20406219
[TBL] [Abstract][Full Text] [Related]
45. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
Pietruck F; Budde K; Salvadori M; Sollinger H; Bourbigot B; Gentil MA; Oppenheimer F
Clin Transplant; 2007; 21(1):117-25. PubMed ID: 17302600
[TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
Pape L; Ehrich JH; Offner G
Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of conversion of mycophenolate mofetil to enteric-coated mycophenolate sodium in Mexican renal transplant children.
Reyes H; Hernández AM; Valverde S; Cataneo A; Mendoza A; Barrera I; Ortíz L; García-Roca P; Lopéz-Martínez B; Castañeda-Hernández G; Medeiros M
Pediatr Transplant; 2010 Sep; 14(6):746-52. PubMed ID: 20412508
[TBL] [Abstract][Full Text] [Related]
49. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the area under the curve of enteric-coated mycophenolate sodium using a limited sampling strategy in Chinese kidney transplant recipients
.
Huang H; Yao X; Wu J; Peng W; Chen J
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):138-146. PubMed ID: 27781422
[TBL] [Abstract][Full Text] [Related]
51. Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study.
Abbud-Filho M; Girón F; Hernández E; Juarez F; Liendo C; Novoa P; Toledo M;
Transplant Proc; 2004; 36(6):1647-9. PubMed ID: 15350440
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
[TBL] [Abstract][Full Text] [Related]
53. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?
Cox VC; Ensom MH
Ther Drug Monit; 2003 Apr; 25(2):137-57. PubMed ID: 12657908
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
[TBL] [Abstract][Full Text] [Related]
55. The evaluation of enteric-coated mycophenolate sodium in cardiac deceased donor liver transplant patients in China.
Wang Z; He JJ; Liu XY; Lin B; Zhang L; Geng L; Zheng S
Immunopharmacol Immunotoxicol; 2015; 37(6):508-12. PubMed ID: 26525836
[TBL] [Abstract][Full Text] [Related]
56. The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients.
AbdElhalim MS; Kenawy AS; Demellawy HHE; Azouz AA; Alghanem SS; Al-Otaibi T; Gheith O; ElMonem MA; Afifi MK; Hussein RRS
Kidney Res Clin Pract; 2020 Dec; 39(4):479-486. PubMed ID: 33214342
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of Mycophenolic Acid and Dose Optimization in Children After Intestinal Transplantation.
Barau C; Mellos A; Chhun S; Lacaille F; Furlan V
Ther Drug Monit; 2017 Feb; 39(1):37-42. PubMed ID: 27898598
[TBL] [Abstract][Full Text] [Related]
58. Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.
Nashan B; Suwelack B; Ivens K; Arns W; Lhotta K; Bourbigot B; Budde K; Fischer W; Pietruck F;
Transplant Proc; 2006 Nov; 38(9):2856-9. PubMed ID: 17112848
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
60. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
Tredger JM; Brown NW; Adams J; Gonde CE; Dhawan A; Rela M; Heaton N
Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
